TriSalus Life Sciences (TLSIW) Free Cash Flow (2021 - 2026)
TriSalus Life Sciences posted quarterly Free Cash Flow of -$6.6 million for Q1 2026, down 26.04% year-on-year from -$9.0 million in Q1 2025, and down 166.01% on a QoQ basis from -$2.5 million in Q4 2025.
TriSalus Life Sciences (TLSIW) has 6 years of Free Cash Flow data on file, last reported at -$6.6 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 26.04% year-over-year to -$6.6 million; the trailing twelve-month figure through Mar 2026 stood at -$19.4 million (up 45.33% YoY), and the FY2025 full-year result was -$18.1 million, up 56.1% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$6.6 million, down from -$2.5 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$425954.0 in Q1 2022 and bottomed at -$22.9 million in Q3 2022.
- The 5-year median for Free Cash Flow is -$8.5 million (2022), against an average of -$8.8 million.
- The widest annual swing landed in 2022, when Free Cash Flow slumped 6166.19%; it then surged 65.41% in 2025.
- A 5-year view of Free Cash Flow shows it stood at -$8.5 million in 2022, then retreated by 12.16% to -$9.5 million in 2023, then jumped by 36.62% to -$6.1 million in 2024, then surged by 58.87% to -$2.5 million in 2025, then slumped by 166.01% to -$6.6 million in 2026.
- The last three Free Cash Flow figures came in at -$6.6 million (Q1 2026), -$2.5 million (Q4 2025), and -$3.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.30 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 305.56 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 449.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 204.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 245.20 Mn |
| 10 | TriSalus Life Sciences | - | - | 7.67 Mn | -6.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.62 Mn |
| Mar 31, 2026 | -6.62 Mn |
| Dec 31, 2025 | -2.49 Mn |
| Dec 31, 2025 | -2.49 Mn |
| Sep 30, 2025 | -3.75 Mn |
| Sep 30, 2025 | -3.75 Mn |
| Jun 30, 2025 | -6.59 Mn |
| Jun 30, 2025 | -6.59 Mn |
| Mar 31, 2025 | -5.25 Mn |
| Mar 31, 2025 | -5.25 Mn |
| Dec 31, 2024 | -6.05 Mn |
| Dec 31, 2024 | -6.05 Mn |
| Sep 30, 2024 | -10.85 Mn |
| Sep 30, 2024 | -10.85 Mn |
| Jun 30, 2024 | -13.42 Mn |
| Jun 30, 2024 | -13.42 Mn |
| Mar 31, 2024 | -10.87 Mn |
| Mar 31, 2024 | -10.87 Mn |
| Dec 31, 2023 | -9.55 Mn |
| Dec 31, 2023 | -9.55 Mn |
| Sep 30, 2023 | -21.84 Mn |
| Sep 30, 2023 | -21.84 Mn |
| Jun 30, 2023 | -9.27 Mn |
| Jun 30, 2023 | -9.27 Mn |
| Mar 31, 2023 | -10.51 Mn |
| Mar 31, 2023 | -10.51 Mn |
| Dec 31, 2022 | -8.51 Mn |
| Dec 31, 2022 | -8.51 Mn |
| Sep 30, 2022 | -22.88 Mn |
| Sep 30, 2022 | -22.88 Mn |
| Jun 30, 2022 | -696,748.00 |
| Jun 30, 2022 | -696,748.00 |
| Mar 31, 2022 | -425,954.00 |
| Mar 31, 2022 | -425,954.00 |
| Dec 31, 2021 | -680,921.00 |
| Dec 31, 2021 | -680,921.00 |
| Sep 30, 2021 | -365,139.00 |
| Sep 30, 2021 | -365,139.00 |
| Jun 30, 2021 | -486,206.00 |
| Jun 30, 2021 | -486,206.00 |
| Mar 31, 2021 | -205,848.00 |
| Mar 31, 2021 | -205,848.00 |